Intravenous immunoglobulin maintenance treatment in myasthenia gravis: a randomized, controlled trial sample size simulation.

Eienbröker, Christian; Seitz, Florian; Spengler, Anna; Kurz, Heike; Seipelt, Maria; Sommer, Norbert; Oertel, Wolfgang H; Timmesfeld, Nina; Tackenberg, Björn

Eienbröker, Christian; Seitz, Florian; Spengler, Anna; Kurz, Heike; Seipelt, Maria; Sommer, Norbert; Oertel, Wolfgang H; Timmesfeld, Nina; Tackenberg, Björn.

Affiliation

Eienbröker C; Clinical Neuroimmunology Group, Department of Neurology, Philipps University, Baldingerstrasse 1, D-35043, Marburg, Germany.

Muscle Nerve ; 50(6): 999-1004, 2014 Dec.

Article in En | MEDLINE | ID: mdl-24710856

Subject(s)

Immunoglobulins, Intravenous/therapeutic use; Myasthenia Gravis/drug therapy; Adult; Aged; Endpoint Determination; Female; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome

Key words

IVIg; RCT; chronic myasthenia gravis; maintenance treatment; sample size calculation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunoglobulins, Intravenous / Myasthenia Gravis Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Muscle Nerve Year: 2014 Type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google